These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 9754024)
21. Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery. Miyanaga M; Miyai T; Nejima R; Maruyama Y; Miyata K; Kato S Acta Ophthalmol; 2009 May; 87(3):300-5. PubMed ID: 19183412 [TBL] [Abstract][Full Text] [Related]
22. The Comparative Efficacy and Tolerability of Diclofenac 0.1% and Bromfenac 0.09% Ophthalmic Solutions after Cataract Surgery. Giannaccare G; Finzi A; Sebastiani S; Greco F; Versura P; Campos EC Curr Eye Res; 2018 Dec; 43(12):1445-1453. PubMed ID: 30009640 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery. Maca SM; Amon M; Findl O; Kahraman G; Barisani-Asenbauer T Am J Ophthalmol; 2010 May; 149(5):777-84. PubMed ID: 20152959 [TBL] [Abstract][Full Text] [Related]
24. Effect of preoperative topical diclofenac on intraocular interleukin-12 concentration and macular edema after cataract surgery in patients with diabetic retinopathy: a randomized controlled trial. Medić A; Jukić T; Matas A; Vukojević K; Sapunar A; Znaor L Croat Med J; 2017 Feb; 58(1):49-55. PubMed ID: 28252875 [TBL] [Abstract][Full Text] [Related]
25. Postoperative management in cataract surgery: nepafenac and preservative-free diclofenac compared. Ylinen P; Taipale C; Lindholm JM; Laine I; Holmström E; Tuuminen R Acta Ophthalmol; 2018 Dec; 96(8):853-859. PubMed ID: 30284393 [TBL] [Abstract][Full Text] [Related]
26. Comparison of ketorolac 0.45% versus diclofenac 0.1% for macular thickness and volume after uncomplicated cataract surgery. Lee TH; Choi W; Ji YS; Yoon KC Acta Ophthalmol; 2016 May; 94(3):e177-82. PubMed ID: 26072977 [TBL] [Abstract][Full Text] [Related]
27. A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells. el-Harazi SM; Ruiz RS; Feldman RM; Villanueva G; Chuang AZ Ophthalmic Surg Lasers; 1998 Jul; 29(7):539-44. PubMed ID: 9674003 [TBL] [Abstract][Full Text] [Related]
28. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study. Tzelikis PF; Vieira M; Hida WT; Motta AF; Nakano CT; Nakano EM; Alves MR Br J Ophthalmol; 2015 May; 99(5):654-8. PubMed ID: 25385061 [TBL] [Abstract][Full Text] [Related]
29. Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs and corticosteroid drugs for prevention of cystoid macular edema after cataract surgery. Li SS; Wang HH; Wang YL; Zhang DW; Chen X Int Ophthalmol; 2023 Jan; 43(1):271-284. PubMed ID: 36065039 [TBL] [Abstract][Full Text] [Related]
30. Prevention of post cataract-surgery cystoid macular edema with nepafenac. Glasser DB J Cataract Refract Surg; 2012 Jan; 38(1):187; author reply 188. PubMed ID: 22153112 [No Abstract] [Full Text] [Related]
31. Efficacy of bromfenac sodium ophthalmic solution in preventing cystoid macular oedema after cataract surgery in patients with diabetes. Endo N; Kato S; Haruyama K; Shoji M; Kitano S Acta Ophthalmol; 2010 Dec; 88(8):896-900. PubMed ID: 19725815 [TBL] [Abstract][Full Text] [Related]
33. [Blood-aqueous barrier after phacoemulsification with posterior chamber lens implantation; foldable acrylate lens vs PMMA lens-- a clinical study on 46 eyes]. Nguyen NX; Tomida I; Küchle M Klin Monbl Augenheilkd; 2000 Oct; 217(4):215-8. PubMed ID: 11098455 [TBL] [Abstract][Full Text] [Related]
34. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery. Flach AJ; Dolan BJ; Donahue ME; Faktorovich EG; Gonzalez GA Ophthalmology; 1998 Sep; 105(9):1775-9. PubMed ID: 9754191 [TBL] [Abstract][Full Text] [Related]
35. New observation of microcystic macular edema as a mild form of cystoid macular lesions after standard phacoemulsification: Prevalence and risk factors. Yoon DH; Kang DJ; Kim MJ; Kim HK Medicine (Baltimore); 2018 Apr; 97(15):e0355. PubMed ID: 29642179 [TBL] [Abstract][Full Text] [Related]
36. Ketorolac-tobramycin combination vs fluorometholone-tobramycin combination in reducing inflammation following phacoemulsification cataract extraction with scleral tunnel incision. Guzey M; Karadede S; Dogan Z; Satici A Ophthalmic Surg Lasers; 2000; 31(6):451-6. PubMed ID: 11095120 [TBL] [Abstract][Full Text] [Related]
37. Fixed-dose combination of 0.1% diclofenac plus 0.3% tobramycin ophthalmic solution for inflammation after cataract surgery: a randomized, comparative, active treatment-controlled trial. Barraquer RI; Alvarez de Toledo JP; Montané D; Escoto RM; Garcia Torres C; Bennani-Tazzi M Eur J Ophthalmol; 1998; 8(3):173-8. PubMed ID: 9793772 [TBL] [Abstract][Full Text] [Related]
38. Additive Effect of Oral Steroid with Topical Nonsteroidal Anti-inflammatory Drug for Preventing Cystoid Macular Edema after Cataract Surgery in Patients with Epiretinal Membrane. Kim S; Kim MK; Wee WR Korean J Ophthalmol; 2017 Oct; 31(5):394-401. PubMed ID: 28913997 [TBL] [Abstract][Full Text] [Related]